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Background: Uveitis is an autoimmune disease of the eye that refers to any of a number of intraocular
inflammatory conditions. Because it is a rare disease, uveitis is often overlooked, and the possible associations
between uveitis and extra-ocular disease manifestations are not well known. The aim of this study was to
characterize uveitis in a large sample of patients and to evaluate the relationship between uveitis and systemic
diseases.
Methods: The present study is a cross-sectional study of a cohort of patients with uveitis. Records from consecutive
uveitis patients who were seen by the Uveitis Service in the Department of Ophthalmology at the Medical
University of Vienna between 1995 and 2009 were selected from the clinical databases. The cases were classified
according to the Standardization of Uveitis Nomenclature Study Group criteria for Uveitis.
Results: Data were available for 2619 patients, of whom 59.9% suffered from anterior, 14.8% from intermediate,
18.3% from posterior and 7.0% from panuveitis. 37.2% of all cases showed an association between uveitis and
extra-organ diseases; diseases with primarily arthritic manifestations were seen in 10.1% of all cases, non-infectious
systemic diseases (i.e., Behçet´s disease, sarcoidosis or multiple sclerosis) in 8.4% and infectious uveitis in 18.7%.
49.4% of subjects suffering from anterior uveitis tested positively for the HLA-B27 antigen. In posterior uveitis cases
29% were caused by ocular toxoplasmosis and 17.7% by multifocal choroiditis.
Conclusion: Ophthalmologists, rheumatologists, infectiologists, neurologists and general practitioners should be
familiar with the differential diagnosis of uveitis. A better interdisciplinary approach could help in tailoring of the
work-up, earlier diagnosis of co-existing diseases and management of uveitis patients.
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Uveitis is a sight-threatening inflammation inside the eye
that affects both the uveal tract (which is composed of the
iris, choroid, and ciliary body and which is the blood-
supplying layer inside of the eye), and adjacent structures
(including the sclera, cornea, vitreous humor, retina and
optic nerve head). Because the disease involves recurrent* Correspondence: talin.barisani@meduniwien.ac.at
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distribution, and reproduction in any mediumintraocular inflammation, uveitis can cause transient or
permanent visual impairment and ocular complications
that are not responsive to therapy [1-4]. Uveitis can occur
either as a co-manifestation of various autoimmune disor-
ders and infections or as a side effect of medications and
toxins, or it can arise as a purely idiopathic ocular inflam-
mation [3,5-10].
The prevalence of uveitis is estimated at 38 cases per
100,000 people, so it meets the criteria for classification as
a rare disease [2,11-19]. It is particularly prevalent in
younger people; the mean age of uveitis patients at the
onset of the disease is less than 40 years of age [20-22].ed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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most common cause of blindness among the working-age
population in the developed world, and its economical
and social impact not yet been evaluated [3,20-22].
The referral of a patient to a uveitis expert is often
delayed because uveitis is commonly unknown, and it is
therefore under-recognized. This delay in diagnosis and re-
ferral increases the risk that uveitis will result in irreversible
damage to various ocular structures. Prompted by the hy-
pothesis that highlighting systemic associations would
optimize the referral of patients with uveitis, we conducted
this systematic review to analyze the distributions of uveitis
subtypes and their extra-organ manifestations.
Patients and methods
The institutional review board of the Medical University of
Vienna approved this study. Since September 1995, data
from all patients referred to the Uveitis Unit of the Depart-
ment of Ophthalmology, Medical University of Vienna, were
systematically recorded. A total of 2619 consecutive patient
records were analyzed for this study.
The uveitis subtypes were classified based on the specific
disease patterns and diagnoses following the recommenda-
tions of the International Uveitis Study Group and the
Standardization of Uveitis Nomenclature (SUN) working
group [23,24]. Guided by the medical history of each patient,
investigations of the anatomical location and character of
the inflammation as well as subsequent diagnostics were
performed using a tailored approach [25,26]. All patients
were treated in a multidisciplinary setting and referred to
the respective specialist if systemic disease was suspected.
Factors considered to satisfy the criteria of specific diagnosis
included well-defined a etiology, typical clinical appearance
and history or classification based on pathological or path-
ognomonic laboratory parameters.
All patients with acute anterior uveitis were typed select-
ively for presence of the HLA-B27 antigen, as HLA-
B27–associated acute anterior uveitis with or withoutFigure 1 Percentage of unclassified and classified cases according tosystemic disease is recognized as a specific uveitis entity
[27]. All uveitis patients with multifocal choroiditis showing
the typical clinical appearance of birdshot choroidopathy
were typed for the HLA-A29 antigen [28]. These two HLA-
antigen predispositions are considered to be pathogno-
monic when combined with the typical clinical appearance.
Diseases belonging to the white dot syndromes which will
be discussed in this article are acute posterior multifocal
placoid pigment epitheliopathy (APMPPE), multiple evan-
escent white dot syndrome (MEWDS), birdshot retinochor-
oidopathy (BSRC), multifocal choroiditis (MFC), punctuate
inner choroidopathy (PIC), acute zonal occult outer retin-
opathy (AZOOR) and serpiginous choroiditis.
Descriptive statistics were computed using SPSS 17.0.
Values are given as ranges, percentages or means± stand-
ard error of the mean, as applicable.
Results
The patient sample comprised 1339 women and 1278 men
(51.1% and 48.2%, respectively). Uveitis occurred at a mean
age of 38.8± 18.3 years (range 1-87). The age at the onset
of the disease was between 17-60 years in 79.8% of the
patients. 9.2% of all cases were children (<17 years) and
11% were elderly patients (>60 years).
The anatomical classification of uveitis was anterior in
59.9%, intermediate in 14.8%, posterior in 18.3% and panu-
veitis in 7% of cases. Figure 1 summarizes the distribution
of unclassified and classified cases in these four groups.
Specific diagnoses
Diseases with primarily arthritic manifestations and uveitis
were diagnosed in 265 cases (10.1%). Of these, the specific a
etiologies included enclosing spondylitis (n=143), rheuma-
toid arthritis (n=42), juvenile idiopathic arthritis (JIA)
(n=58), reactive arthritis (n=5) and psoriatic arthritis
(n=17).
Infectious uveitis was diagnosed in 495 patients (19.0%).
Diagnoses included 226 viral [ocular herpes virus reactivationanatomical localization of uveitis.
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systemic cytomegaly virus infection (CMV) (n=5), other
(n=10)], 198 parasitic [toxplasomosis (n=173), 18 toxocaro-
sis (n=18), other (n=7)], 47 bacterial and 24 fungal infec-
tions. Of these cases, 99 were associated with current
systemic infections (Table 1).
Of the purely ocular infections, 187 cases were diagnosed
with herpetic anterior uveitis, 14 with acute retinal necrosis
(ARN), 173 with ocular toxoplasmosis and 18 with ocular
toxocarosis.
Non-infectious systemic diseases with primarily non-
arthritic manifestations were diagnosed in 221 cases (8.4%).
These included Behçet´s disease (n=49), sarcoidosis (n=64),
Crohn´s disease (n=30), multiple sclerosis (MS) (n=25),
ulcerative colitis (n=14), Whipple´s disease (n=2), Vogt-
Koyanagi-Harada disease (VKH) (n=11), systemic lupus
erythematosus (SLE) (n=7) and masquerade syndromes
(MASQ) (n=19).
Ocular syndromes such as HLA-B27–associated acute an-
terior uveitis without systemic disease (HLA-B27 AAU)
(n=271), Fuchs’ heterochromic cyclitis (HCF) (n=88),
serpiginous choroidopathy (n=23), multifocal choroiditis
(n=86), birdshot choroidopathy (n=10), acute posterior
multifocal placoid pigment epitheliopathy (APMPPE) (n=8),
multiple evanescent white dot syndrome (n=6), glaucomat-
ous cyclonic crisis (n=10) and sympathetic ophthalmia
(n=2), were found in 503 (19.2%) cases.
Anatomical location and specific entities
In the anterior uveitis (AU) group, specific diagnoses could be
established in 60.9% of cases. HLA-B27–associated acute an-
terior uveitis was diagnosed in 414 cases (30.5% of AU). These
cases were either related to underlying HLA-B27–associated
systemic diseases such as enclosing spondylitis (n=143) or to
purely ocular disease (271 cases).
Herpetic anterior uveitis and HCF were found in 11.4%
and 4.5% of cases, respectively. JIA was seen in 3.4% of AU
patients. In addition, uveitis was associated with sarcoidosis
in 2.1% of cases, and Behçet´s disease in 0.9%. Systemic
infections, MASQ, glaucomatous cyclonic crisis, and ul-
cerative colitis were each seen in less than 1% of AU
patients.
75% of patients with intermediate uveitis remained with-
out specific diagnosis. 51.5% of all IU patients were diag-
nosed with pars planets; 4.9% of these cases were associatedTable 1 Current systemic infections agents as causes of active
Viral (n = 21) Bacterial (n = 47)
VZV (n = 14) Mycobacterium tuberculosis (n = 21)
CMV (n = 5) Chlamydia trachomatis (n = 10)
Other (n = 2) Treponema pallidum (n = 9)
Borrelia Burgdorferi (n = 7)
VZV: varicella virus infection; CMV: cytomegaly virus infection.with MS, 3.6% with HCF with dense vitreous opacities, 1.5%
with sarcoidosis and <1% with scleroderma or toxocara
canis.
In the posterior uveitis group, a specific diagnosis could
be established in 78.1% of patients. Ocular toxoplasmosis
was present in 29%, followed by multifocal choroiditis in
17.7% and serpiginous choroidopathy in 4.8%. Posterior
uveitis was associated with systemic infections in 5.8%, sar-
coidosis in 2.5%, VKH in 1.8%, ocular toxocarosis in 1.4%
and Behçet´s disease in 2.5% of cases. ARN, MASQ, Whip-
ple's disease and Crohn’s disease were each diagnosed in
less than 1% of posterior Uveitis patients.
For patients with panuveitis, a specific diagnosis could
be established in 80.4% of cases. Panuveitis was associated
with systemic infections in 26.7%, ocular toxoplasmosis in
15.8%, sarcoidosis in 7.1%, Behçet's disease in 11.4%, VKH
in 3% and acute retinal necrosis in 4.3% of cases.
Of the 2619 Uveitis cases, 39.4% stayed unclassified
regarding specific diagnoses. The most predominant spe-
cific entity was HLA-B27–associated anterior uveitis
(HLA-B27 AAU, with or without systemic disease), which
was found in 19.5% of all patients, followed by ocular toxo-
plasmosis in 6.6%, herpetic uveitis in 7.1%, white dot syn-
dromes (WDS) in 5.5%, systemic infections in 4%, HCF in
3.4%, sarcoidosis in 2.4%, Behçet’s disease in 1.9%, JIA in
2.2% and rheumatoid arthritis in 1.6% of the patients.
Table 2 summarizes the most common etiologies of uveitis
cases and their anatomical distribution.
Age at onset of disease
The distribution of the patients’ age at disease onset is
shown in Figure 2. The mean age at the onset of disease
for the different specific entities can be seen in Table 3.
In the <7 years age group (n=91, 3.45% of all patients),
anterior uveitis represented the predominant anatomic
group. The spectrum of specific diagnoses was narrow; JIA
(29.6%), pars planets (10.3%), ocular toxoplasmosis (9.9%),
sarcoidosis (2.2%), ocular herpes infection (6.6%), reactive
arthritis (2.6%) and systemic infection (3.3%) were found,
35.1% of cases remained unclassified. In children between
the ages of 7 and 17 years at the onset of disease (n=215),
an increase in the proportion of intermediate uveitis was
noted (35.3%). Specific diagnoses were established in 53.9%
of the cases. These included JIA (10.6%), ocular toxoplasmo-
sis (14.4%), ocular herpes infection (3.7%), HLA-B27+ AAUuveitis
Parasites (n = 7) Fungal (n = 24)
Ascaris lumbricoides (n = 2) Candida albicans (n = 22)
Filaria (n = 2) Aspergillus fumigatus (n = 2
Giarda lamblia (n = 2)
Plasmodium falciparum (n = 1))
Table 2 Etiology of endogenous uveitis cases
SUN-localisation Total
Anterior Intermediate Posterior Panuveitis
Unclassified 598 290 105 36 1029
HLA-B27 AAU 480 480
Viral infections 183 9 17 17 226
Parasitic infections 7 5 153 33 198
Ocular syndromes 79 15 142 14 250
Sarcoidosis 34 7 10 13 64
JIA 52 1 0 5 58
Behçet’s disease 14 2 12 21 49
Other autoimmune diseases 31 7 5 5 48
Bacterial infections 14 10 11 12 47
Rheumatoid arthritis 36 5 0 0 41
MS 4 19 2 0 25
Fungal infections 2 3 7 12 24
MASQ 7 4 5 4 20
JIA: juvenile idiopathic arthritis; MS: multiple sclerosis; MASQ: masquerade syndromes.
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sis (0.9%), systemic infections (1.7%) and sarcoidosis (3.2%),
with serpiginous choroiditis, multifocal choroiditis, SLE and
chronic polychondritis each observed in less than 1% of
patients.
In two-thirds of the patients, disease onset occurred be-
tween 17 and 60 years of age. In this age group, the disease
entities were diverse and are listed in Table 2.Figure 2 Distribution of patients’ age at disease onset.Onset of disease after the age of 61 years was found in
13.5% of the patients; the largest group had anterior uveitis
(63.1%). The diversity of specific entities was again reduced;
44.7% of patients were without specific diagnoses, 17.5%
had ocular herpes infections, 6.2% had systemic infections,
8.4% had HLA-B27+ AAU, 2.8% had rheumatoid arthritis,
2.5% had ocular toxoplasmosis, 2.5% had WDS, 1.4% had
serpiginous choroiditis, 2.2% had ocular toxocarosis, 1.9%
Table 3 Specific entities found in at least 5 patients and
age at onset of disease
Mean Min Max Main (yrs)
JIA 10.8 1 29 <17
APMPPE 20.2 17 27 17-40
Reactive arthritis 34.7 7 66 >17
SLE 30.7 13 53 36-60
Toxoplamosis 29.2 1 79 17-40
Crohn´s disease 34.7 18 64 17-40
Reiter´s disease 35.5 13 64 17-35
Ulcerative colitis 43.4 24 49 17-60
HCF 32.4 12 70 <40
Behcet´s disease 31.1 15 55 <40
Ocular toxocarosis 47.2 11 71 >17
HLA-B27 only eye 37.8 9 82 17-60
Unclassified cases 39.5 2 87 17-60
Psoriatric arthritis 39.8 23 49 36-60
Ancyl. spondylitis 39.5 17 75 17-60
MFC 38.6 16 77 17-60
MS 35.9 14 77 17-40
Sarcoidosis 40.1 5 78 17-60
Serpiginous 45.3 15 76 >36
ARN 43.9 7 62 1 > 17
Ocular herpes 47.8 2 88 >36
Systemic infections 47.5 3 80 17-60
VKH 42.6 30 78 >30
Birdshot 51.4 32 75 36-60
MASQ 55.2 10 80 >36
For each classification, mean age of onset of disease (mean), minimum age at
onset of disease (min), maximum age at onset of disease (max) and the main
age group where this specific entity is found (main).
JIA: juvenile idiopathic arthritis; APMPPE: acute posterior multifocal placoid
pigment epitheliopathy; SLE: systemic lupus erythematosus; HCF: Fuchs’
heterochromic cyclitis; MFC: multifocal choroiditis; MS: multiple sclerosis; ARN:
acute retinal necrosis; VKH: Vogt-Koyanagi-Harada disease; MASQ: masquerade
syndromes.
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birdshot chorioretinopathy or reactive arthritis disease.
There were no cases of Behçet´s disease and just one case
of MS in the group with onset ages of over 60 years.
Discussion
In this study, we were able to establish specific diagnoses
in 60.6% of 2619 patients; this is consistent with previous
studies that reported ranges between 47 and 75% [29]. The
relative frequencies of anatomical classifications are com-
parable to data published in other Middle European series
from tertiary care centers but differ from the data of other
Northern European countries, where up to 96% of the
cases were reported to have anterior uveitis [30-35]. In theposterior and panuveitis groups, the rate of unclassified
cases was the lowest at around 20%, and in the posterior
uveitis group the frequency of toxoplasmosis was even
higher than that among unclassified cases.
Overall, the largest diagnostic group comprised patients
with ocular syndromes, followed by those with infectious
diseases, arthritic diseases and, lastly, non-infectious sys-
temic diseases.
When considering all patients, the major specific entities
were HLA-B27+AAU with or without systemic disease
(19.5%), herpetic uveitis (7.1%) and ocular toxoplasmosis
(6.6%).
The differential diagnosis of uveitis has changed over
time. Tuberculosis and syphilis, the former main causes of
uveitis, are now diagnosed in only 2.4% of patients [36,37].
More recently, however, increased frequency of these dis-
eases has been noted. Factors that affect the changing pat-
terns of uveitis include the rise of autoimmune diseases,
appearance of new infections, description of new disease
entities, better treatment of certain diseases, availability of
new diagnostic tests and more refined classification of uve-
itis cases.
In the present study, the frequencies of different uveitis
entities in different age groups were analyzed. In small chil-
dren, only a few entities were discerned, including JIA, ocu-
lar toxoplasmosis, herpetic uveitis, pars planets, sarcoidosis,
reactive arthritis, systemic infections and idiopathic anterior
uveitis. With increasing age, the diversity of possible entities
grew, reaching a peak between 30–40 years. In the elderly,
the spectrum of specific diagnoses was again narrower; the
major specific entities consisted of infections (herpes virus
and toxoplasmosis) and masquerade syndromes. Some uve-
itis entities such as HCF, Behçet´s disease, and APMPPE
appeared to affect adolescents or young adults with the
greatest frequency; in children, JIA-associated Uveitis was
most frequent. Nevertheless, most entities were observed in
all age groups.
The high percentage of uveitis patients with systemic dis-
eases and infections underpins the necessity of an interdis-
ciplinary approach to uveitis therapy. Furthermore,
rheumatologists and ophthalmologists have to be aware that
a plethora of systemic autoimmune diseases and infections,
as well as purely ocular syndromes, can cause uveitis. Infec-
tious agents were involved in the cross a etiology of uveitis
in almost 19% of all cases. This high percentage was mainly
due to the high numbers of ocular toxoplasmosis (7.0%) and
herpetic uveitis (7.1%) patients. These numbers imply that
correct classification can have a decisive impact on the suc-
cess or failure of therapies, and that immunosuppressive
medications should not be given without ruling out infec-
tious a etiology. However, the diagnostic quest should not
lead to generalized and extensive investigations that generate
unnecessary costs. The recommended course is a tailored
approach in the hands of uveitis specialists and/or
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experience. This would help to reinforce existing inter-
national guidelines, raise the standards of treatment, facili-
tate drug development, and shed light on the prognosis and
course of the disease.
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